A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure

Regulatory Toxicology and Pharmacology

Volumn 55, Issue 1, 2009, Pages 97-109

  Shepperd, Christopher J ^a   Eldridge, Alison C ^a   Mariner, Derek C ^a   McEwan, Michael ^a   Errington, Graham ^a   Dixon, Michael ^b  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b Dixon Consultancy   (United Kingdom)

Author keywords

Biomarkers; Carcinogen; Cigarette; Dose; Exposure; Filter analysis; Nicotine; Smoke

Indexed keywords

3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLCYSTEINE DERIVATIVE; ACROLEIN; BIOLOGICAL MARKER; CIGARETTE SMOKE; COTININE; GLUCURONIDE; NICOTINE; PYRENE;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CHEMICAL ANALYSIS; CIGARETTE SMOKING; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENVIRONMENTAL EXPOSURE; GERMANY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SALIVA LEVEL; URINE LEVEL;

ACROLEIN; ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHEMISTRY TECHNIQUES, ANALYTICAL; ENVIRONMENTAL EXPOSURE; FEMALE; FILTRATION; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NICOTINE; NITROSAMINES; PYRENES; REFERENCE VALUES; SMOKE; SMOKING; TOBACCO; YOUNG ADULT;

EID: 69049094827     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.06.006     Document Type: Article

References (60)

1. Armitage A.K., Dixon M., Frost B.E., Mariner D.C., and Sinclair N.M. The effect of tobacco blend additives on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Chem. Res. Toxicol. 17 (2004) 537-544
2. Baker R.R., Dixon M., and Hill C. The incidence and consequences of filter vent blocking amongst british smokers. Beitr. Tabakforsch. Int. 18 (1998) 71-83
3. Baker R.R., and Dixon M. The retention of tobacco smoke constituents in the human respiratory tract. Inhalation Toxicol. 18 (2006) 255-294
4. Bates C., McNeil A., Jarvis M., and Gray N. The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive. Tob. Control 8 (1998) 225-235
5. Benowitz N., Jacob III P., Fong I., and Guota S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268 (1994) 296-303
6. Benowitz N. Compensatory Smoking of Low Yield Cigarettes. Smoking and Tobacco Control Monograph 13. Bethesda Maryland, US Dept. Health and Human Services, National Institutes of Health vol. 3 (2001), Springer pp. 39-63
7. Bernstein D. A review of the influence of particle size, puff volume, and inhalation pattern on the deposition of cigarette smoke particles in the respiratory tract. Inhal. Toxicol. 16 (2004) 675-689
8. Burns D.M., Dybing E., Gray N., Hecht S., Anderson C., Scanner T., et al. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organisation TobReg proposal. Tob. Control 17 (2008) 132-141
9. Byrd G.D., Robinson J.H., Caldwell W.S., and deBethizy J.D. Comparison of measured and FTC-predicted nicotine uptake in smokers. Psychopharmacology (Berl.) 122 (1995) 95-103
10. Canada Tobacco Reporting Regulations, 2000. SOR/2000-273.
11. Carmella S.G., Le Ka K.A., Upadhyaya P., and Hecht S.S. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Chem. Res. Toxicol. 15 (2002) 545-550
12. Comer A.K., and Creighton D.E. The effect of experimental conditions on smoking behaviour. In: Thornton R.E. (Ed). Smoker Behaviour (1978), Churchill Livingstone, Edinburgh 76-86
13. Curvall M., Kazemi-Vala E., and Englund G. Conjugation pathways in nicotine metabolism. In: Adlkofer F., and Thurau K. (Eds). Effects of Nicotine on Biological Systems (1991), Birkhauser-Verlag, Basel 69-75
14. Davis D.L., and Nielsen M.T. Tobacco: production, chemistry and technology. World agriculture series. Blackwell Sci. 11 (1999) 346
15. European Union Directive, 2001. 37/EC concerning the manufacture, presentation and sale of tobacco products. Official Journal of the European Communities.
16. Federal Trade Commission, 1966. Cigarettes and related matters: methods to be employed in determining tar and nicotine content. Federal Regist. 31, 14278.
17. Federal Trade Commission, 1967a. Cigarettes: testing for tar and nicotine content. Federal Regist. 32, 11178.
18. Federal Trade Commission, 1967b. FTC to Begin Cigarette Testing: News Release of the Federal Trade Commission, Washington DC.
19. Feng S., Plunkett S., Lam K., Kapur S., Muhammad R., Jin Y., Zimmermann M., Mendes P., Kinser R., and Roethig H.J. A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking. Inhalation Toxicol. 19 (2006) 169-179
20. Feng S., Kapur S., Sarkar M., Muhammad R., Mendes P., Newland K., and Roethig H.J. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol. Lett.. 173 (2007) 101-106
21. Hammond D., Fong G.T., Cummings K.M., O'Connor R.J., Giovino G.A., and McNeill A. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiol. Biomarkers Prev. 15 8 (2006) 1495-1501
22. Health Canada. Determination of "Tar," Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke-Official Method (1999), Health Canada, Ottawa (SOR-2000-272)
23. Hecht S.S., Carmella S.G., Chen M., Dor Koch J.F., Miller A.T., Murphy S.E., et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59 (1999) 590-596
24. Hecht S.S., Murphy S.E., Carmella S.G., Li S., Jensen J., Le C., et al. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 693-698
25. ICH Harmonized Tripartite Guidelines for Good Clinical Practice, 1996. Directive 91/507/EEC, The Rules Governing Medicinal Products in the European Community.
26. Independent Scientific Committee on Smoking and Health, 1988. Independent Scientific Committee on Smoking and Health: Fourth report of the Independent Scientific Committee on Smoking and Health. Her Majesty's Stationary Office.
27. Institute of Medicine, 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, National Academy Press, Washington, DC, p. 10.
28. International Organization for Standardization, 2000. Cigarettes - determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine, ISO 4387:2000, Geneva, Switzerland.
29. Jarvis M.J., Boreham R., Primatesta P., Feyerabend C., and Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J. Natl. Cancer Inst. 93 (2001) 134-138
30. Jarvis M.J., Primatesta P., Erens B., Feyerabend C., and Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tobacco Res. 5 3 (2003) 349-355
31. Lewis V.B. Outliers in Statistical Data. second ed. (1984), John Wiley and Sons
32. Li H., Krieger R.I., and Li Q.X. Improved HPLC method for analysis of 1-hydroxypyrene in human urine specimens of cigarette smokers. Sci. Total Environ. 257 (2000) 147-153
33. Mariner, D.C., McEwan, M., St. Charles, F.K., Krautter, G., Appleton, S., 2005. Dose-Response Relationships for Urinary Biomarkers of Selected Tobacco Smoke Constituents. 11th Annual Meeting and 7th Annual European Conference of the Society for Research on Nicotine and Tobacco. Prague, Czech Republic. Available from:.
34. Mascher D.G., Mascher H.J., Scherer G., and Schmid E.R. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J. Chromatogr. B Biomed. Sci. Appl. 750 (2001) 163-169
35. Massachusetts, 1997. Massachusetts General Laws, Ch94, Sect. 307B, 105 Code of Massachusetts Regulations 660.000 er seq.
36. Meger M., Meger-Kossien I., Deitrich M., Tricker A., Scherer G., and Adlkofer F. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in Urine of Smokers. Eur. J. Cancer Prev. 5 (1996) 121-124
37. Merlo F., Andreassen A., Weston A., Pan C.F., Haugen A., Valerio F., et al. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 147-155
38. Moldoveanu S.C., Coleman III W., and Wilkins J. Determination of carbonyl compounds in exhaled cigarette smoke. Beitr. Tabakforsch. Int. 22 (2007) 346-357
39. Moldoveanu S.C., Coleman III W., and Wilkins J. Determination of polycyclic aromatic hydrocarbons in exhaled smoke. Beitr. Tabakforsch. Int. 23 (2008) 85-97
40. Moldoveanu S.C., and St. Charles F.K. Differences in the chemical composition of the particulate phase of inhaled and exhaled cigarette mainstream smoke. Beitr. Tabakforsch. Int. 22 (2007) 290-302
41. National Institutes of Health, 1996. The FTC cigarette test method for determining tar, nicotine and carbon monoxide yields of US cigarettes. Smoking and Tobacco Control Monograph 7. Bethesda Maryland, US Dept. Health and Human Services, Public Health Services, National Institutes of Health, National Cancer Institute. NIH Pub No. 02-4028.
42. National Institutes of Health, 2001. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monograph 13. Bethesda Maryland, US Dept. Health and Human Services, National Institutes of Health, National Cancer Institute. NIH Pub No. 02-5074.
43. Ossip-Klein D.J., Martin J.E., Lomax B.D., Prue D.M., and Davis C.J. Assessment of smoking topography generalisation across laboratory, clinical and naturalistic settings. Addictive Behaviours 8 (1983) 11-17
44. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology 145 (1999) 1-20
45. Scherer G., Engl J., Urban M., Gilch G., Janket D., and Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 47 (2007) 171-183
46. Shepperd C.J., St. Charles F.K., Lien M., and Dixon M. Validation of methods for determining consumer smoked cigarette yields from cigarette filter analysis. Beitr. Tabakforsch. Int. 22 (2006) 176-184
47. Simon P., Morele Y., Delsaut P., and Nicot T. Automated column-switching high-performance liquid chromatography method for the determination of 1-hydroxypyrene in human urine. J. Chromatogr. B Biomed. Sci. Appl. 732 (1999) 91-101
48. Snedecor W.G.C. Statistical Methods. eighth ed. (1991), Iowa State University
49. St. Charles F.K., Krautter G.R., Dixon M., and Mariner D.C. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology (Berl.) 189 (2006) 345-354
50. Stanek W., Krenmayr P., Scherer G., and Schmid E.R. Quantitative determination of N-acetyl(-l-)cysteine derivatives in human urine by tandem mass spectrometry. Biol. Mass Spectrom. 22 (1993) 133-142
51. Stefansky W. Rejecting outliers by maximum normal residual. Annal. Math. Stat. 42 (1971) 35-45
52. Strickland P., and Kang D. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol. Lett. 108 (1999) 191-199
53. Tukey J.W. Exploratory Data Analysis vol. 2 (1977), Addish-Wesley, Reading, MA pp. 39-44
54. Ueda K., Kawachi I., Nakamura M., Nogami H., Shirokawa N., Masui S., et al. Cigarette nicotine yields and nicotine intake among Japanese male workers. Tob. Control 11 (2002) 55-60
55. US Department of Health and Human Services, 1988. The Health Consequences of Smoking: Nicotine Addiction. Public Health Services, Washington, DC.
56. Watson C., McCraw J., Polzin G., Ashley D., and Barr D. Development of a method to assess cigarette smoke intake. Environ. Sci. Technol. 38 (2004) 248-253
57. WHO Study group on Tobacco Product Regulation, 2004. Guiding principles for the development of tobacco product research and testing capacity and proposed protocols for the initiation of tobacco product testing: recommendation 1. World Health Organisation, Geneva.
58. Wilkenfeld J., Henningfield J., Slade J., Burns D., and Pinney J. It's time for a change: cigarette smokers deserve meaningful information about their cigarettes. J. Natl. Cancer Inst. 92 (2000) 90-92
59. World Medical Association, 2004. Declaration of Helsinki - Recommendations guiding Physicians in Biomedical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975, 35th WMA General Assembly, Venice, Italy, October 1983, 41st WMA General Assembly, Hong Kong, September 1989, 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996 and 52nd WMA General Assembly, Edinburgh, Scotland, October 2000; Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002, Note of Clarification on Paragraph 30 added by the WMA General Assembly, Tokyo 2004.
60. Zacny J.P., Stitzer M.L., Brown F.J., Yingling J.E., and Griffiths R.R. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J. Pharmacol. Exp. Ther. 240 (1987) 554-564